Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Glenmark Pharmaceuticals (GLENMARK.NSE) Q2 2025 Earnings
GLENMARK.NSE
23
May
Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
10.05
11.64
13.23
14.82
Details
Expected EPS
12.04076014482
Actual EPS
10.050551856419998
Surprise EPS
-1.99
Surprise Percent
+16.53%
Description
Glenmark Pharmaceuticals (GLENMARK.NSE) has reported earnings of 10.050551856419998 per share for Q2 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login